# Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients

> **NCT01163825** · PHASE1 · UNKNOWN · sponsor: **NsGene A/S** · enrollment: 6 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Nerve Growth Factor

## Key facts

- **NCT ID:** NCT01163825
- **Lead sponsor:** NsGene A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-01
- **Primary completion:** 2011-12
- **Final completion:** —
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2010-07-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01163825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01163825, "Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01163825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*